Articles with public access mandates - Paul HuttonLearn more
Available somewhere: 12
Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial
AP Morrison, D Turkington, M Pyle, H Spencer, A Brabban, G Dunn, ...
The Lancet 383 (9926), 1395-1403, 2014
Mandates: National Institute for Health Research, UK
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial
AP Morrison, M Pyle, A Gumley, M Schwannauer, D Turkington, ...
The Lancet Psychiatry 5 (8), 633-643, 2018
Mandates: Chief Scientist Office, Scottish Executive, National Institute for Health …
The paranoia-as-defence model of persecutory delusions: A systematic review and meta-analysis
P Murphy, RP Bentall, D Freeman, S O'Rourke, P Hutton
The Lancet Psychiatry, 2018
Mandates: National Institute for Health Research, UK
Decision-making ability in psychosis: A systematic review and meta-analysis of the magnitude, specificity and correlates of impaired performance on the Iowa and Cambridge …
A Woodrow, S Sparks, V Bobrovskaia, C Paterson, P Murphy, P Hutton
Psychological Medicine, 2018
Mandates: National Institute for Health Research, UK
Cognitive behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT
AP Morrison, M Pyle, A Gumley, M Schwannauer, D Turkington, ...
Health Technology Assessment 23 (7), 2019
Mandates: National Institute for Health Research, UK
Suicidal ideation in people with psychosis not taking antipsychotic medication: Do negative appraisals and negative metacognitive beliefs mediate the effect of symptoms?
P Hutton, F Di Rienzo, D Turkington, H Spencer, P Taylor
Schizophrenia bulletin 45 (1), 37-47, 2019
Mandates: National Institute for Health Research, UK
Quetiapine immediate release v. placebo for schizophrenia: systematic review, meta-analysis and reappraisal
P Hutton, PJ Taylor, L Mulligan, S Tully, J Moncrieff
The British Journal of Psychiatry 206 (5), 360-370, 2015
Mandates: National Institute for Health Research, UK
Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trial
M Pyle, J Norrie, M Schwannauer, D Kingdon, A Gumley, D Turkington, ...
BMC psychiatry 16 (1), 1-12, 2016
Mandates: National Institute for Health Research, UK
Cognitive Behavioral Therapy for antipsychotic-free schizophrenia spectrum disorders: Does therapy dose influence outcome?
HM Spencer, M McMenamin, R Emsley, D Turkington, G Dunn, ...
Schizophrenia Research, 2018
Mandates: National Institute for Health Research, UK
The effect of reducing the ‘jumping to conclusions’ bias on treatment decision-making capacity in psychosis: a randomised controlled trial with mediation analysis
D Turner, A MacBeth, A Larkin, S Moritz, K Livingstone, A Campbell, ...
Schizophrenia Bulletin, 2018
Mandates: National Institute for Health Research, UK
Should people with psychosis be supported in choosing cognitive therapy as an alternative to antipsychotic medication: A commentary on a commentary
P Hutton
Schizophrenia Research, 2018
Mandates: National Institute for Health Research, UK
Accelerating the development of a psychological intervention to restore treatment decision-making capacity in patients with schizophrenia-spectrum disorder: study protocol for …
P Hutton, J Kelly, CDJ Taylor, B Williams, R Emsley, CH Alexander, ...
Pilot and Feasibility Studies 9 (117), 2023
Mandates: National Institute for Health Research, UK
Publication and funding information is determined automatically by a computer program